Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
9xtM7rczSa07WQbV